Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies
Older age and chronic polypharmacy were key predictors of therapy changes and discontinuation. Prostaglandin analogues and beta-blocker agents demonstrated greater therapy stability. These findings emphasize further need for targeted interventions to improve adherence and persistence, particularly among older patients and those with complex medication regimens.
Authors
- Alessandro Nobili (ORCID: https://orcid.org/0000-0002-7813-0572)
- Alessia Antonella Galbussera (ORCID: https://orcid.org/0000-0003-0163-1034)
- Robert Neal Weinreb (ORCID: https://orcid.org/0000-0001-9553-3202)
- Luca Pasina (ORCID: https://orcid.org/0000-0002-4777-1350)
- Luciano Quaranta (ORCID: https://orcid.org/0000-0002-5462-1713)
- Olivia Leoni (ORCID: https://orcid.org/0000-0002-6906-2424)
- Alessio Novella (ORCID: https://orcid.org/0000-0001-5927-811X)
- Mauro Tettamanti (ORCID: https://orcid.org/0000-0001-7345-0887)
- Ida Fortino (ORCID: https://orcid.org/0009-0005-6006-0376)
Institutions
- Mario Negri Institute for Pharmacological Research (IT)
- University of California San Diego (US)
- Centro Diagnostico Italiano (IT)
- Regione Lombardia
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1007/s12325-025-03247-y
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.71